Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) EBT Margin (2021 - 2025)

PAVmed has reported EBT Margin over the past 5 years, most recently at 3403.7% for Q4 2025.

  • Quarterly results put EBT Margin at 3403.7% for Q4 2025, down 1482370.0% from a year ago — trailing twelve months through Dec 2025 was 2469.0% (up 1684.0% YoY), and the annual figure for FY2025 was 2469.0%, down 341815.0%.
  • EBT Margin for Q4 2025 was 3403.7% at PAVmed, up from 120220.0% in the prior quarter.
  • Over the last five years, EBT Margin for PAVM hit a ceiling of 252750.0% in Q1 2021 and a floor of 205400.0% in Q2 2025.
  • Median EBT Margin over the past 5 years was 4980.72% (2023), compared with a mean of 3488.49%.
  • Biggest five-year swings in EBT Margin: tumbled -26313783bps in 2022 and later surged 23462037bps in 2025.
  • PAVmed's EBT Margin stood at 6559.67% in 2021, then crashed by -234bps to 21939.29% in 2022, then skyrocketed by 92bps to 1659.49% in 2023, then surged by 788bps to 11420.0% in 2024, then plummeted by -130bps to 3403.7% in 2025.
  • The last three reported values for EBT Margin were 3403.7% (Q4 2025), 120220.0% (Q3 2025), and 205400.0% (Q2 2025) per Business Quant data.